Combination therapy with a long-acting amylin analogue and a glucagon-like peptide-1 (GLP-1) receptor agonist results in ...

The observational data can’t capture details like the timing, amount, and type of exposure. Still, there’s a “safety signal.” ...

Elevations in cardiac troponin (cTn) after long bouts of aerobic exercise are not associated with subclinical coronary artery ...

These data suggest that private equity-acquired hospitals are cherry-picking the healthiest patients as part of an effort to ...

Most cases are subclinical, but given the newness of the therapy, it’s necessary to keep tabs on the issue going forward.

Though the Acurate neo and neo2 valves are no longer available, there are lessons here for other self-expanding TAVI ...

The test of nonaerobic functioning may raise awareness that people need to work on balance and flexibility as they age.

Outcomes in the observational study were better among patients treated by surgeons who regularly do ablations.

The results suggest toxicity may not be as pervasive as previously thought, which argues for more-personalized monitoring.

Responding to MAUDE data, some have safety concerns but others aren’t surprised to see more events in higher-risk patients.

Using the PREVENT risk equation, one-fifth were at high risk over 10 years, rising to two-thirds over the next 30 years.

However, acquired hospitals may be inappropriately selecting patients and doing more profitable cardiac caths.